AP2011005679A0 - Drop pill for treating coronary heart disease and preparation thereof. - Google Patents
Drop pill for treating coronary heart disease and preparation thereof.Info
- Publication number
- AP2011005679A0 AP2011005679A0 AP2011005679A AP2011005679A AP2011005679A0 AP 2011005679 A0 AP2011005679 A0 AP 2011005679A0 AP 2011005679 A AP2011005679 A AP 2011005679A AP 2011005679 A AP2011005679 A AP 2011005679A AP 2011005679 A0 AP2011005679 A0 AP 2011005679A0
- Authority
- AP
- ARIPO
- Prior art keywords
- preparation
- heart disease
- coronary heart
- drop pill
- treating coronary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810152009 | 2008-10-06 | ||
PCT/CN2009/074339 WO2010043156A1 (zh) | 2008-10-06 | 2009-09-30 | 一种治疗冠心病的滴丸及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2011005679A0 true AP2011005679A0 (en) | 2011-04-30 |
Family
ID=42106231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2011005679A AP2011005679A0 (en) | 2008-10-06 | 2009-09-30 | Drop pill for treating coronary heart disease and preparation thereof. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20110195136A1 (pt) |
AP (1) | AP2011005679A0 (pt) |
AU (1) | AU2009304440A1 (pt) |
BR (1) | BRPI0920617A2 (pt) |
CA (1) | CA2738614A1 (pt) |
IL (1) | IL212018A0 (pt) |
MX (1) | MX2011003647A (pt) |
WO (1) | WO2010043156A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657730A (zh) * | 2012-06-05 | 2012-09-12 | 西藏天力商贸有限公司 | 一种抗高原反应的红景天口含剂 |
CN102940694B (zh) * | 2012-10-31 | 2014-06-25 | 成都医路康医学技术服务有限公司 | 一种治疗心脑血管病的药物组合物 |
CN103735617A (zh) * | 2013-12-13 | 2014-04-23 | 王树林 | 复方丹参口腔崩解片及其制备方法 |
CN103800482B (zh) * | 2014-03-06 | 2015-08-12 | 李兵晖 | 一种治疗心肌缺血的药物组合物及其制备方法和应用 |
CN104374844A (zh) * | 2014-11-13 | 2015-02-25 | 贵州信邦制药股份有限公司 | 丹参药材中水溶性成分的含量测定方法及其应用 |
CN106483260A (zh) * | 2015-10-09 | 2017-03-08 | 厦门中药厂有限公司 | 一种八宝丹胶囊质量标准控制方法 |
CN106420836B (zh) * | 2016-06-24 | 2019-10-25 | 孙彪 | 一种林蛙油滴丸及其制备方法 |
CN107596146A (zh) * | 2017-10-26 | 2018-01-19 | 张纪星 | 一种治疗冠状动脉粥样硬化和脑血管硬化疾病的中药复方 |
CN108888707A (zh) * | 2018-07-13 | 2018-11-27 | 安徽松山堂国药股份有限公司 | 一种银杏滴丸剂及其制备方法 |
CN110243988B (zh) * | 2019-06-28 | 2021-09-14 | 广西中医药大学 | 壮药白花九里明hplc指纹图谱的建立方法 |
CN111068368A (zh) * | 2020-01-15 | 2020-04-28 | 开封嘉骏生物科技有限公司 | 一种用于沉淀畜禽用中药提取液中杂质的组方及其应用 |
CN112946118B (zh) * | 2021-02-01 | 2023-04-07 | 贵州金桥药业有限公司 | 一种药物指纹图谱的测定方法及其指纹图谱 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1161140C (zh) | 2001-11-09 | 2004-08-11 | 天津天士力制药股份有限公司 | 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途 |
CN100553615C (zh) * | 2003-12-11 | 2009-10-28 | 天津天士力制药股份有限公司 | 一种治疗心脑血管疾病的药物 |
CN1785247B (zh) * | 2004-12-06 | 2010-08-11 | 天津天士力制药股份有限公司 | 一种崩解片及其制备方法 |
-
2009
- 2009-09-30 AP AP2011005679A patent/AP2011005679A0/xx unknown
- 2009-09-30 WO PCT/CN2009/074339 patent/WO2010043156A1/zh active Application Filing
- 2009-09-30 MX MX2011003647A patent/MX2011003647A/es unknown
- 2009-09-30 BR BRPI0920617A patent/BRPI0920617A2/pt not_active Application Discontinuation
- 2009-09-30 CA CA2738614A patent/CA2738614A1/en not_active Abandoned
- 2009-09-30 US US13/122,800 patent/US20110195136A1/en not_active Abandoned
- 2009-09-30 AU AU2009304440A patent/AU2009304440A1/en not_active Abandoned
-
2011
- 2011-03-29 IL IL212018A patent/IL212018A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010043156A1 (zh) | 2010-04-22 |
MX2011003647A (es) | 2011-05-25 |
IL212018A0 (en) | 2011-06-30 |
AU2009304440A1 (en) | 2010-04-22 |
US20110195136A1 (en) | 2011-08-11 |
CA2738614A1 (en) | 2010-04-22 |
BRPI0920617A2 (pt) | 2015-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2011005679A0 (en) | Drop pill for treating coronary heart disease and preparation thereof. | |
HUS1600048I1 (hu) | Készítmény Fabry-kór kezelésére | |
GB2465897B (en) | Respiratory disease treatment | |
IL225637A0 (en) | The compositions, tablets containing such compositions, their use and a process for their preparation | |
SI2376537T1 (sl) | Humana protitelesa zoper humani faktor tkiva | |
EP2443449A4 (en) | DETERMINATION OF CORONARY ARTERY DISEASE RISK | |
ZA200805939B (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
ZA201101369B (en) | Multilayered blood product | |
IL192809A0 (en) | Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients | |
PL2234631T3 (pl) | Związki i metody stosowane w terapii choroby naczyniowej | |
GB0707208D0 (en) | Novel disease treatments | |
EP2393503A4 (en) | AYURVEDA FORMULATION FOR THE TREATMENT OF CORONARY DISEASES | |
GB0701456D0 (en) | Treatment for respiratory disease | |
GB2447884B (en) | Treatment for skin disease | |
ZA201005394B (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative | |
EP2190990A4 (en) | PTHRP, its isoforms and antagonist for the diagnosis and treatment of diseases | |
GB0814488D0 (en) | Respiratory disease treatment | |
GB0823568D0 (en) | Respiratory disease treatment | |
GB0604130D0 (en) | Treatment for skin disease | |
TWI372054B (en) | A pharmaceutical composition for preventing or treating cardiovascular disease | |
GB0721923D0 (en) | Novel compounds and improved treatments for cardiac and cardiovascular disease | |
GB0700577D0 (en) | Composition for heart disease | |
GB0821490D0 (en) | Molecular methods for the treatment of disease. | |
HU0500437D0 (en) | Medicine against heart burn | |
GB0811950D0 (en) | Disease prevention and treatment |